Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure.
We define cardiomyokines as heart-derived secreted proteins that affect cardiovascular function via autocrine, paracrine and/or endocrine mechanisms. The subject of this review is the cardiomyokine, mesencephalic astrocyte-derived neurotrophic factor (MANF). The expression of MANF is increased in the ischemic heart, in part, through activation of ER stress, a condition that drastically impairs the expression and secretion of most cardiomyokines. This novel function of MANF suggests that it may have important roles in the ER stressed, ischemic heart. Consistent with this are recent findings showing that MANF protects against ischemic damage, and that it is anti-hypertrophic. Accordingly, in light of its function as a potentially secreted cardiomyokine, MANF has translational potential as a novel therapy for ischemic heart disease. This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure."
The SDSU Heart Institute and the Department of Biology, San Diego State University, San Diego, CA 92182, USA. cglembotski@sciences.sdsu.edu
Christopher C
CC
Glembotski
D000595:Amino Acid Sequence; D000818:Animals; D006332:Cardiomegaly / Q000188:drug therapy / Q000503:physiopathology*; D059865:Endoplasmic Reticulum Stress; D015870:Gene Expression; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D008969:Molecular Sequence Data; D058990:Molecular Targeted Therapy; D009414:Nerve Growth Factors / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D057170:Translational Research, Biomedical
C099695:MANF protein, human; D009414:Nerve Growth Factors